Anthony Fok
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Anthony Fok has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
Belinda Lin
Western Hlth, Melbourne, Vic, Australia
1 shared publication- Catriona McLean
Department of Anatomical Pathology, Alfred Hospital
1 shared publication Cristina Mateevici
Western Hlth, Melbourne, Vic, Australia
1 shared publication- Ernest Butler
Department of Medicine, Monash Health, Monash University, Clayton, VIC, Australia; Frankston Neurology, Frankston, VIC, Australia; Department of Neurology, Peninsula Health, Frankston, VIC, Australia
1 shared publication - Ronil Vikesh Chandra
Monash Imaging, Monash Health, Clayton, Victoria, Australia
1 shared publication - Trevor J. Williams
Respiratory Medicine Alfred Hospital Melbourne VIC Australia
1 shared publication
Latest Publications
- 20 July 2016
- Published by SAGE Publications in Multiple Sclerosis Journal
- Vol. 22 (11) , 1495-1498
Interferon beta-1a long-term therapy related to pulmonary arterial hypertension in multiple sclerosis patients
We report two patients with relapsing remitting multiple sclerosis (RRMS) on interferon (IFN) beta-1a treatment for more than 7 years who developed pulmonary arterial hypertension (PAH). Patient 1 developed severe PAH requiring lung transplantation. Histology showed typical proliferative lesions including plexiform lesions consistent with PAH. Patient 2 ceased IFN beta-1a, and their symptoms stabilised. Both cases highlight IFN beta-1a treatment as a potential risk factor for PAH. PAH needs to be considered as a diagnosis in patients on long-term IFN beta-1a treatment who develop new-onset respiratory symptoms.
- 20 July 2016
- Published by SAGE Publications in Multiple Sclerosis Journal
- Vol. 22 (11) , 1495-1498
Interferon beta-1a long-term therapy related to pulmonary arterial hypertension in multiple sclerosis patients
We report two patients with relapsing remitting multiple sclerosis (RRMS) on interferon (IFN) beta-1a treatment for more than 7 years who developed pulmonary arterial hypertension (PAH). Patient 1 developed severe PAH requiring lung transplantation. Histology showed typical proliferative lesions including plexiform lesions consistent with PAH. Patient 2 ceased IFN beta-1a, and their symptoms stabilised. Both cases highlight IFN beta-1a treatment as a potential risk factor for PAH. PAH needs to be considered as a diagnosis in patients on long-term IFN beta-1a treatment who develop new-onset respiratory symptoms.
- Open Access
- 1 November 2015
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 21 (11) , 2074-2076
Encephalitis-Associated Human Metapneumovirus Pneumonia in Adult, Australia
Human metapneumovirus pneumonia, most commonly found in children, was diagnosed in an adult with encephalitis. This case suggests that testing for human metapneumovirus RNA in nasopharyngeal aspirate and cerebrospinal fluid samples should be considered in adults with encephalitis who have a preceding respiratory infection,
- 1 November 2015
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 21 (11) , 2074-2076
Open AccessEncephalitis-Associated Human Metapneumovirus Pneumonia in Adult, Australia
Human metapneumovirus pneumonia, most commonly found in children, was diagnosed in an adult with encephalitis. This case suggests that testing for human metapneumovirus RNA in nasopharyngeal aspirate and cerebrospinal fluid samples should be considered in adults with encephalitis who have a preceding respiratory infection,